217 filings
8-K
PTN
Palatin Technologies Inc.
15 May 24
Palatin Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
8:40am
8-K
PTN
Palatin Technologies Inc.
15 Feb 24
Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
9:00am
8-K
PTN
Palatin Technologies Inc.
1 Feb 24
Palatin Announces $10 Million Registered Direct Offering
5:16pm
8-K
PTN
Palatin Technologies Inc.
20 Dec 23
Palatin Completes Sale of Vyleesi® to
9:00am
8-K
PTN
Palatin Technologies Inc.
18 Dec 23
Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American
4:45pm
8-K
ijhzysq
14 Nov 23
Palatin Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
12:00am
8-K
msb7t
24 Oct 23
PTN - Palatin Announces $5 Million Registered Direct Offering
4:05pm
8-K
i7w3mmmo
19 Oct 23
Palatin Announces Preliminary Quarter Ended
8:01am
8-K
i1k6i242qojhs54y
13 Oct 23
Palatin Receives Notice of Non-Compliance from NYSE American
4:31pm
8-K
xnj4k2
28 Sep 23
Palatin Reports Fourth Quarter and Fiscal Year Ended 2023 Financial
8:02am
8-K
3s8vkab
8 Sep 23
Palatin to Present at the H.C. Wainwright
8:00am
8-K
mx1p0sj1r8s osnu
7 Sep 23
Palatin Completes Enrollment in Phase 3 MELODY-1 Study of PL9643 For the Treatment of Patients with Dry Eye Disease
8:49am
8-K
qngv9ezyen1ghpax
10 Aug 23
Palatin Initiates Clinical Program for Bremelanotide Co-Formulated with a PDE5i for the Treatment of ED in Patients Non-Responsive to PDE5i Treatment
8:15am
8-K
u1h 1kmi8jk48
8 Aug 23
Palatin Provides Update on VYLEESI® Collaborations
8:00am
8-K
ccp0gzdnoq
7 Aug 23
Other Events
8:00am
8-K
mohflrb1f1zb3u
4 Aug 23
Palatin to Participate in Canaccord Genuity’s 43rd Annual Growth Conference
8:00am
8-K
t77vvmzoj7rl
11 Jul 23
Palatin Announces Preliminary Fourth Quarter Fiscal 2023
8:25am
8-K
u50whyxia4dhjb 7i
21 Jun 23
Submission of Matters to a Vote of Security Holders
9:01am
8-K
8wlu0spptj3c7
30 May 23
Palatin Presents Preclinical Diabetic Nephropathy Data at the International Podocyte Conference
9:30am
8-K
tvsrwb
16 May 23
Palatin Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
8:15am